HAP Trading’s Precigen PGEN Stock Holding History

HAP Trading’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-74,440	Closed	-$570K	–	1346
2019 Q2	$570K	Sell	74,440 -65,591	-47%	-$353K	0.04%	318
2019 Q1	$737K	Buy	140,031 +17,634	+14%	+$122K	0.07%	225
2018 Q4	$800K	Buy	+122,397	New	+$1.37M	0.05%	281

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HAP Trading's PGEN Position: Q3 2019 in Review

HAP Trading sold out of Precigen (PGEN) in Q3 2019, closing a stake of 74,440 shares — an estimated $570K sold.

HAP Trading first reported a position in PGEN in Q4 2018 and held it in 3 quarters. The position peaked at $800K in Q4 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

HAP Trading reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
HAP Trading sold 74,440 Precigen shares in Q3 2019, an estimated $570K.
HAP Trading first reported a position in Precigen in Q4 2018 and held it in 3 quarters.
HAP Trading's Precigen position peaked at $800K in Q4 2018.
170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on HAP Trading's 13F filing for Q3 2019, filed 12 Nov 2019.